Biomea Fusion Stock Shares Owned By Insiders

BMEA Stock  USD 11.25  0.40  3.43%   
Biomea Fusion fundamentals help investors to digest information that contributes to Biomea Fusion's financial success or failures. It also enables traders to predict the movement of Biomea Stock. The fundamental analysis module provides a way to measure Biomea Fusion's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biomea Fusion stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Biomea Fusion Company Shares Owned By Insiders Analysis

Biomea Fusion's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Insiders Shares

 = 

Executives Shares

+

Employees

More About Shares Owned By Insiders | All Equity Analysis

Current Biomea Fusion Shares Owned By Insiders

    
  25.03 %  
Most of Biomea Fusion's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biomea Fusion is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Biomea Shares Owned By Insiders Driver Correlations

Understanding the fundamental principles of building solid financial models for Biomea Fusion is extremely important. It helps to project a fair market value of Biomea Stock properly, considering its historical fundamentals such as Shares Owned By Insiders. Since Biomea Fusion's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Biomea Fusion's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Biomea Fusion's interrelated accounts and indicators.
0.980.96-0.98-0.810.80.580.981.00.960.990.96-0.530.720.96-0.530.72
0.980.99-0.96-0.780.770.391.00.980.970.970.97-0.50.690.98-0.50.69
0.960.99-0.94-0.70.720.350.990.960.930.960.93-0.40.590.96-0.40.57
-0.98-0.96-0.940.84-0.76-0.59-0.96-0.99-0.94-0.99-0.940.63-0.77-0.940.63-0.72
-0.81-0.78-0.70.84-0.88-0.51-0.78-0.8-0.88-0.77-0.880.86-0.96-0.840.86-0.95
0.80.770.72-0.76-0.880.510.770.780.890.740.89-0.520.720.88-0.520.83
0.580.390.35-0.59-0.510.510.390.580.440.580.44-0.40.470.42-0.40.48
0.981.00.99-0.96-0.780.770.390.980.970.970.97-0.50.690.98-0.50.69
1.00.980.96-0.99-0.80.780.580.980.951.00.95-0.530.710.96-0.530.7
0.960.970.93-0.94-0.880.890.440.970.950.931.0-0.570.770.99-0.570.81
0.990.970.96-0.99-0.770.740.580.971.00.930.93-0.510.690.94-0.510.67
0.960.970.93-0.94-0.880.890.440.970.951.00.93-0.570.770.99-0.570.81
-0.53-0.5-0.40.630.86-0.52-0.4-0.5-0.53-0.57-0.51-0.57-0.94-0.521.0-0.81
0.720.690.59-0.77-0.960.720.470.690.710.770.690.77-0.940.72-0.940.95
0.960.980.96-0.94-0.840.880.420.980.960.990.940.99-0.520.72-0.520.74
-0.53-0.5-0.40.630.86-0.52-0.4-0.5-0.53-0.57-0.51-0.571.0-0.94-0.52-0.81
0.720.690.57-0.72-0.950.830.480.690.70.810.670.81-0.810.950.74-0.81
Click cells to compare fundamentals
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Competition

Based on the latest financial disclosure, 25.03% of Biomea Fusion are shares owned by insiders. This is 64.89% higher than that of the Biotechnology sector and 76.52% higher than that of the Health Care industry. The shares owned by insiders for all United States stocks is 148.07% lower than that of the firm.

Biomea Shares Owned By Insiders Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biomea Fusion's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biomea Fusion could also be used in its relative valuation, which is a method of valuing Biomea Fusion by comparing valuation metrics of similar companies.
Biomea Fusion is currently under evaluation in shares owned by insiders category among its peers.

Biomea Fusion ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Biomea Fusion's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Biomea Fusion's managers, analysts, and investors.
Environmental
Governance
Social

Biomea Fundamentals

About Biomea Fusion Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Biomea Fusion's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biomea Fusion using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biomea Fusion based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Biomea Fusion offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biomea Fusion's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biomea Fusion Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biomea Fusion Stock:
Check out Biomea Fusion Piotroski F Score and Biomea Fusion Altman Z Score analysis.
For information on how to trade Biomea Stock refer to our How to Trade Biomea Stock guide.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomea Fusion. If investors know Biomea will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomea Fusion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.90)
Return On Assets
(0.48)
Return On Equity
(0.85)
The market value of Biomea Fusion is measured differently than its book value, which is the value of Biomea that is recorded on the company's balance sheet. Investors also form their own opinion of Biomea Fusion's value that differs from its market value or its book value, called intrinsic value, which is Biomea Fusion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomea Fusion's market value can be influenced by many factors that don't directly affect Biomea Fusion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomea Fusion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomea Fusion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomea Fusion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.